全文获取类型
收费全文 | 319篇 |
免费 | 21篇 |
出版年
2023年 | 2篇 |
2022年 | 4篇 |
2021年 | 5篇 |
2020年 | 4篇 |
2019年 | 8篇 |
2018年 | 7篇 |
2017年 | 3篇 |
2016年 | 5篇 |
2015年 | 7篇 |
2014年 | 16篇 |
2013年 | 21篇 |
2012年 | 22篇 |
2011年 | 18篇 |
2010年 | 18篇 |
2009年 | 13篇 |
2008年 | 12篇 |
2007年 | 10篇 |
2006年 | 9篇 |
2005年 | 13篇 |
2004年 | 9篇 |
2003年 | 15篇 |
2002年 | 22篇 |
2001年 | 6篇 |
2000年 | 3篇 |
1998年 | 3篇 |
1995年 | 2篇 |
1993年 | 3篇 |
1988年 | 2篇 |
1986年 | 7篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 2篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 7篇 |
1978年 | 2篇 |
1976年 | 2篇 |
1975年 | 2篇 |
1973年 | 3篇 |
1971年 | 3篇 |
1956年 | 2篇 |
1952年 | 2篇 |
1908年 | 3篇 |
1907年 | 2篇 |
1899年 | 3篇 |
1889年 | 1篇 |
1888年 | 1篇 |
1887年 | 2篇 |
1882年 | 2篇 |
排序方式: 共有340条查询结果,搜索用时 500 毫秒
51.
Genetic suppressor elements (GSEs) are biomolecules derived from a gene or genome of interest that act as transdominant inhibitors of biological functions presumably by disruption of critical biological interfaces. We exploited a cell death reporter cell line for hepatitis C virus (HCV) infection, n4mBid, to develop an iterative selection/enrichment strategy for the identification of anti-HCV GSEs. Using this approach, a library of fragments of an HCV genome was screened for sequences that suppress HCV infection. A 244 amino acid gene fragment, B1, was strongly enriched after 5 rounds of selection. B1 derives from a single-base frameshift of the enhanced green fluorescent protein (eGFP) which was used as a filler during fragment cloning. B1 has a very high net positive charge of 43 at neutral pH and a high charge-to-mass (kDa) ratio of 1.5. We show that B1 expression specifically inhibits HCV replication. In addition, five highly positively charged B1 fragments produced from progressive truncation at the C-terminus all retain the ability to inhibit HCV, suggesting that a high positive charge, rather than a particular motif in B1, likely accounts for B1’s anti-HCV activity. Another supercharged protein, +36GFP, was also found to strongly inhibit HCV replication when added to cells at the time of infection. This study reports a new methodology for HCV inhibitor screening and points to the anti-HCV potential of positively charged proteins/peptides. 相似文献
52.
Bed segregation in a fluidized bed bioreactor profoundly influenced biofilm thickness and microbial activities of the biofilm along the bed height. Bioparticles coated with a thin biofilm, observed at the bottom of the reactor, had a higher specific activity in propylene glycol and n-propanol degradation than in thick biofilms developed at the top of the reactor. Although no significant difference was observed in specific activity for propionate and acetate along the reactor flow axis, more total propionate and acetate conversion occurred in regions of thicker biofilm accumulation. 相似文献
53.
54.
A rapid and hazardous reagent free protocol for genomic DNA extraction suitable for genetic studies in plants 总被引:2,自引:0,他引:2
Protocols for genomic DNA extraction from plants are generally lengthily, since they require that tissues be ground in liquid
nitrogen, followed by a precipitation step, washing and drying of the DNA pellet, etc. This represents a major challenge especially
when several hundred samples must be screened/analyzed within a working day. There is therefore a need for a rapid and simple
procedure, which will produce DNA quality suitable for various analyses. Here, we describe a time and cost efficient protocol
for genomic DNA isolation from plants suitable for all routine genetic screening/analyses. The protocol is free from hazardous
reagents and therefore safe to be executed by non-specialists. With this protocol more than 100 genomic DNA samples could
manually be extracted within a working day, making it a promising alternative in genetic studies of large-scale genomic screening
projects. 相似文献
55.
56.
Rositsa Zamfirova Elina Tzvetanova Albena Alexandrova Lubomir Petrov Polina Mateeva Almira Pavlova Margarita Kirkova Simeon Todorov 《Central European Journal of Biology》2009,4(2):170-178
The effects of nociceptin(1–13)NH2 (N/OFQ(1–13)NH2) and its structural analogue [Orn9]N/OFQ(1–13)NH2 on acute carrageenan (CG)-induced peripheral inflammation and paw antioxidant status were studied. CG was injected intraplantarly
in the right hind paw of rats and the volume of the inflamed paw was measured each 30 min for a period of 4h. When administered
simultaneously with CG, N/OFQ(1–13)NH2 decreased the paw volume, whereas if injected 15 min before CG it had no effect. [Orn9]N/OFQ(1–13)NH2 produced the opposite effects at the same time-intervals of its administration. We also investigated whether these neuropeptides
influence CG-induced changes in cell antioxidant system, especially at the 4th hour of CG administration. CG alone decreased
the glutathione level and superoxide dismutase activity, as measured in post-nuclear homogenate of the inflamed paw. However,
CG injection increased glutathione peroxidase and glucose-6-phospate dehydrogenase activities, while the activity of glutathione
reductase was unchanged. The peptides themselves did not change all measured parameters. Moreover, neither N/OFQ(1–13)NH2 nor [Orn9]N/OFQ(1–13)NH2 modified CG-induced changes in the antioxidant status, regardless of the time of their injection (simultaneously or 15 min
before CG). The present results suggest that N/OFQ(1–13)NH2 and [Orn9]N/OFQ(1–13)NH2 most likely affect the neuronal inflammation, rather than act as pro- or antioxidants. 相似文献
57.
58.
Antibodies have proved to be a valuable mode of therapy for numerous diseases, mainly owing to their high target binding affinity and specificity. Unfortunately, antibodies are also limited in several respects, chief amongst those being the extremely high cost of manufacture. Therefore, non-antibody binding proteins have long been sought after as alternative therapies. New binding protein scaffolds are constantly being designed or discovered with some already approved for human use by the FDA. This review focuses on protein scaffolds that are either already being used in humans or are currently being evaluated in clinical trials. Although not all are expected to be approved, the significant benefits ensure that these molecules will continue to be investigated and developed as therapeutic alternatives to antibodies. Based on the location of the amino acids that mediate ligand binding, we place all the protein scaffolds under clinical development into two general categories: scaffolds with ligand-binding residues located in exposed flexible loops, and those with the binding residues located in protein secondary structures, such as α-helices. Scaffolds that fall under the first category include adnectins, anticalins, avimers, Fynomers, Kunitz domains, and knottins, while those belonging to the second category include affibodies, β-hairpin mimetics, and designed ankyrin repeat proteins (DARPins). Most of these scaffolds are thermostable and can be easily produced in microorganisms or completely synthesized chemically. In addition, many of these scaffolds derive from human proteins and thus possess very low immunogenic potential. Additional advantages and limitations of these protein scaffolds as therapeutics compared to antibodies will be discussed. 相似文献
59.
60.
Bienvenu Glinma Sika D. S. Kpoviessi Fernand A. Gbaguidi Coco N. Kapanda Joanne Bero Joëlle Quetin-Leclercq Mansourou Moudachirou Jacques Poupaert Georges C. Accrombessi Emma W. Gachomo Lamine Baba-Moussa Simeon O. Kotchoni 《Molecular biology reports》2014,41(3):1617-1622
Thiosemicarbazones have become one of the promising compounds as new clinical candidates due to their wide spectrum of pharmaceutical activities. The wide range of their biological activities depends generally on their related aldehyde or ketone groups. Here, we report the pharmacological activities of some thiosemicarbazones synthesized in this work. Benzophenone and derivatives were used with N(4)-phenyl-3-thiosemicarbazide to synthesize corresponding five thiosemicarbazones (1–5). Their structures were characterized by spectrometrical methods analysis IR, NMR 1H & 13C and MS. The compounds were then screened in vitro for their antiparasitic activity and toxicity on Trypanosoma brucei brucei and Artemia salina Leach respectively. The selectivity index of each compound was also determined. Four thiosemicarbazones such as 4, 2, 3 and 1 reveal interesting trypanocidal activities with their half inhibitory concentration (IC50) equal to 2.76, 2.83, 3.86 and 8.48 μM respectively, while compound 5 (IC50 = 12.16 μM) showed a moderate anti-trypanosomal activity on parasite. In toxicity test, except compound 1, which showed a half lethal concentration LC50 >281 μM, the others exerted toxic effect on larvae with LC50 of 5.56, 13.62, 14.55 and 42.50 μM respectively for thiosemicarbazones 4, 5, 3 and 2. In agreement to their selectivity index, which is greater than 1 (SI >1), these compounds clearly displayed significant selective pharmaceutical activities on the parasite tested. The thiosemicarbazones 2–5 that displayed significant anti-trypanosomal and cytoxicity activities are suggested to have anti-neoplastic and anti-cancer activities. 相似文献